Skin organoid culture hydrogel and preparation method thereof
The skin organoid culture hydrogel prepared by bioorthogonal click chemical synthesis method solves the problems of complex components of existing hydrogels and irreconcilable mechanical properties, and realizes the adjustability of biocompatibility and mechanical properties. In vivo transplantation and customized culture.
Patent Information
- Application Number
- CN202410940288.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-15
- Publication Date
- 2024-11-05
AI Technical Summary
The existing skin organoid culture hydrogels are derived from abnormal tissues, with complex components, batch differences, and irreconcilable mechanical properties, resulting in weak research.
Using a method based on bioorthogonal click chemical synthesis, skin organoid culture hydrogels with excellent biocompatibility and adjustable mechanical properties are prepared. By adjusting the concentration, molecular weight and stoichiometric ratio of macromolecular materials, we form suitable skin composition. hydrogel.
The hydrogel has clear composition, low immunogenicity and adjustable mechanical properties. It is suitable for in vivo transplantation, has better biocompatibility, and has few defects in the network structure of the hydrogel. It can be customized according to the skin composition and cell type. .
Smart Images

Figure CN118892579A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the fields of organoids, biomedical engineering, cell biology and so on, and in particular to a skin organoid culture hydrogel and a preparation method thereof. Background Art
[0002] The skin is the first line of defense of the human body. Severe skin trauma can cause fluid loss, infection, and even threaten the patient's life. Currently, the treatment methods for skin trauma have problems such as limited skin sources and immune rejection.
[0003] Organoids remove the confounding variables that may be introduced by animal models, but offer a higher degree of complexity compared to homogenized 2D cell cultures. By combining a high level of physiological relevance with the inexpensiveness of in vitro manipulation, organoids have the potential to assist or replace in vitro experiments using primary cells or immortalized cell lines and animals in many cases. In addition, organoids are highly genetically stable in culture, maintaining the genotype and phenotype of the source tissue.
[0004] Therefore, skin organoids are expected to provide a new cell source for the clinical treatment of skin trauma and promote technical research in the field of wound treatment. However, the construction of skin organoids at this stage relies on commercial hydrogels, such as Matrigel, which are derived from mouse tumor cell culture extracts and contain a large amount of natural tissue components to facilitate cell adhesion growth. However, this type of hydrogel is derived from abnormal tissues, has complex components, has batch-to-batch differences, and has non-adjustable mechanical properties. The high dependence on Matrigel has led to the current weak research on the skin organoid system.
[0005] In the past 20 years, materials synthesized based on bioorthogonal click chemistry have become a unique class of biomaterials. Orthogonal chemical pairs that can react with each other are used to couple to the main components of the extracellular matrix such as collagen and hyaluronic acid, and then the modified macromolecular materials are simply mixed and reacted to form hydrogels. By adjusting the concentration and molecular weight of the macromolecular materials, the stoichiometric ratio of the orthogonal reaction to the macromolecular materials, the reaction conditions (pH, temperature), etc., hydrogels with different network structures or cross-linking densities can be prepared. Therefore, the hydrogels prepared by this method can meet the needs of skin organoid construction and can be customized according to the cells that make up the skin. Summary of the invention
[0006] The technical problem solved by the present invention is that the matrix gel currently used for organoid culture comes from abnormal tissues, has complex ingredients, has batch-to-batch differences, and has unadjustable mechanical properties.
[0007] In view of the problems existing in the existing commercial organoid culture hydrogels, the present invention designs a skin organoid culture hydrogel and a preparation method thereof. The hydrogel of the present invention has excellent biocompatibility, adjustable mechanical properties, scalable production, clear ingredients, low immunogenicity, and can be customized according to the purpose and cell type.
[0008] It should be noted that, in the present invention, unless otherwise specified, the specific meaning of "including" in relation to composition limitations and descriptions includes both open-ended "including", "comprising" and similar meanings, and closed-ended "consisting of..." and similar meanings.
[0009] In order to solve the above-mentioned technical problems, the present invention adopts the following solutions:
[0010] A method for preparing a hydrogel for culturing skin organoids, characterized by comprising the following steps:
[0011] Step 1: Synthesis of collagen tetrazine;
[0012] Step 2: Synthesis of hyaluronic acid norbornene;
[0013] Step 3: Synthesis of four-arm polyethylene glycol norbornene;
[0014] Step 4: Preparation of collagen tetrazine solution A;
[0015] Step 5: Preparation of norbornene-modified compound mixed solution B;
[0016] Step 6: Preparation of hydrogel for skin organoid culture.
[0017] Furthermore, the synthesis of collagen tetrazine described in step 1 specifically comprises the following steps:
[0018] Step 1.1: Under normal temperature and stirring conditions, dissolve collagen in a weak alkaline buffer solution, and fully stir and dissolve to obtain a collagen solution with a concentration of 1.25wt%-2.5wt%;
[0019] Step 1.2: Weigh methyl tetrazine active ester (Tz-NHS) and dissolve it in DMSO solution. After it is completely dissolved, add it dropwise to the collagen solution of step 1.1, so that the molar ratio of Tz-NHS to the amino group in collagen is NHS:NH2=0.5-3.0. React for 6-24 hours at room temperature with stirring, add pure water to terminate the reaction, dialyze, and freeze-dry to obtain pink sponge-like collagen tetrazine, which is stored in a refrigerator for later use;
[0020] Wherein, the collagen described in step 1 includes type I collagen, type III collagen, type IV collagen, and type XVII collagen.
[0021] Furthermore, the synthesis method of hyaluronic acid norbornene described in step 2 specifically comprises the following steps:
[0022] Step 2.1: Dissolve sodium hyaluronate in a weakly acidic buffer solution at room temperature with stirring to completely dissolve the sodium hyaluronate solution;
[0023] Step 2.2: Weigh N-hydroxysuccinimide (NHS) and 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (EDC) respectively, add the sodium hyaluronate solution prepared in step 2.1 under stirring to make the molar ratio of NHS:EDC:COOH=1:1:1-10:10:1, stir and perform activation reaction for 0.5-2 hours to obtain an activated sodium hyaluronate solution;
[0024] Step 2.3: Measure 5-norbornene-2-methylamine (Nb-NH2) solution, and add the solution of step 2.2 dropwise under stirring to make the molar ratio of Nb-NH2:COOH=1.0-10.0, stir and react for 8-48 hours, add pure water to terminate the reaction, dialyze and freeze-dry to obtain white spongy hyaluronic acid norbornene, which is stored in a refrigerator for later use;
[0025] Wherein, the molecular weight of the hyaluronic acid described in step 2 includes 10-15kDa, 40.2kDa, and 150-300kDa.
[0026] Further, the synthesis method of the four-arm polyethylene glycol norbornene described in step 3 specifically comprises the following steps:
[0027] Step 3.1: Dissolve the four-arm polyethylene glycol amino in a buffer solution under stirring at room temperature, and stir to completely dissolve the four-arm polyethylene glycol amino solution;
[0028] Step 3.2: Weigh the powder of nadic anhydride (Nb-COOH), add the four-arm polyethylene glycol amino solution prepared in step 3.1 under stirring, so that the molar ratio Nb-COOH:NH2=0.5-2.0. During the dissolution of nadic anhydride, monitor the pH value of the reaction solution and adjust it. React at room temperature with stirring, add pure water to terminate the reaction, dialyze and freeze-dry to obtain white sponge-like polyethylene glycol nadic anhydride, which is stored in a refrigerator for later use.
[0029] Furthermore, the preparation of the collagen tetrazine solution A in step 4 is specifically as follows: weigh the collagen tetrazine in step 1 and dissolve it in a buffer solution, and aseptically treat it to obtain a collagen tetrazine solution;
[0030] The preparation of the norbornene modified compound mixed solution B described in step 5 is specifically as follows:
[0031] Step 5.1: Weigh the hyaluronic acid norbornene prepared in step 2 and dissolve it in a buffer solution, and perform aseptic treatment to obtain a hyaluronic acid norbornene solution;
[0032] Step 5.2: dissolving the four-arm polyethylene glycol norbornene in step 3 in a buffer solution, and aseptically treating the solution to obtain a four-arm polyethylene glycol norbornene solution;
[0033] Step 5.3: The hyaluronic acid norbornene solution, four-arm polyethylene glycol norbornene solution and buffer solution in the above step are uniformly mixed at a certain volume ratio to obtain a norbornene-modified compound mixed solution B.
[0034] Furthermore, the specific operation for preparing the skin organoid culture hydrogel described in step 6 is: the collagen tetrazine solution A in step 4 and the norbornene modified compound mixed solution B in step 5 are mixed evenly, transferred into the device, and allowed to stand for 0.5-2 hours to form the skin organoid culture hydrogel.
[0035] The invention also discloses a hydrogel prepared by a method for preparing a skin organoid culture hydrogel.
[0036] The present invention also discloses an application of a hydrogel in skin organoid culture, which is characterized by comprising the following steps:
[0037] Wherein, the application method 1 comprises the following steps:
[0038] Step 1: Preparation of collagen tetrazine solution A containing cells;
[0039] Step 2: Preparation of norbornene-modified compound mixed solution B;
[0040] Step 3: Evenly mix the cell-containing collagen tetrazine solution A in step 1 and the norbornene-modified compound mixed solution B in step 2 in equal volumes, transfer them into a cell culture device as required, allow them to stand for a while to form a hydrogel, then add cell culture medium for culture, and thus obtain skin organoids;
[0041] Alternatively, the second application method includes the following steps:
[0042] Step 1: Preparation of collagen tetrazine solution A;
[0043] Step 2: Preparation of a mixed solution B of norbornene-modified compounds containing cells;
[0044] Step 3: Mix equal volumes of collagen tetrazine solution A in step 1 and norbornene-modified compound mixed solution B containing cells in step 2, transfer them into a cell culture device as needed, let them stand to form a hydrogel, add cell culture medium and culture them to obtain skin organoids.
[0045] Furthermore, the application method 1 specifically comprises the following steps:
[0046] Step 1: weigh the collagen tetrazine in step 1 and dissolve it in a buffer solution, and aseptically treat it to obtain a collagen tetrazine solution; mix the collagen tetrazine solution and the primary epidermal stem cells evenly to obtain a collagen tetrazine solution A containing cells, wherein the final concentration of the collagen tetrazine is 1.42wt%-2.4wt%, and the number of cells is 1*10 5 Pieces / mL-1*10 6 Pieces / mL;
[0047] Step 2, weighing the hyaluronic acid norbornene in step 2 and dissolving it in a buffer solution, and aseptically treating it to obtain a hyaluronic acid norbornene solution, wherein the final concentration of the hyaluronic acid norbornene is 2.0wt%-3.0wt%;
[0048] Weigh the four-arm polyethylene glycol norbornene in step 3 and dissolve it in a buffer solution, and aseptically treat it to obtain a four-arm polyethylene glycol norbornene solution, wherein the final concentration of the four-arm polyethylene glycol norbornene is 2.0 wt%-5.0 wt%;
[0049] The hyaluronic acid norbornene solution and the four-arm polyethylene glycol norbornene solution are mixed uniformly in a certain ratio to obtain a norbornene modified compound mixed solution B;
[0050] Step three, mix equal volumes of the cell-containing collagen tetrazine solution A in step one and the norbornene-modified compound mixed solution B in step two, transfer them into a cell culture device as needed, let them stand to form a hydrogel, add cell culture medium and culture them to obtain skin organoids.
[0051] Furthermore, the second application method comprises the following steps:
[0052] Step 1, weighing the collagen tetrazine prepared in step 1 and dissolving it in a buffer solution, and aseptically treating the solution to obtain a collagen tetrazine solution A; wherein the final concentration of the collagen tetrazine is 1.42wt%-2.4wt%;
[0053] Step 2, weighing the hyaluronic acid norbornene in step 2 and dissolving it in a buffer solution, and aseptically treating it to obtain a hyaluronic acid norbornene solution, wherein the final concentration of the hyaluronic acid norbornene is 2.0wt%-3.0wt%;
[0054] Weigh the four-arm polyethylene glycol norbornene in step 3 and dissolve it in a buffer solution, and aseptically treat it to obtain a four-arm polyethylene glycol norbornene solution, wherein the final concentration of the four-arm polyethylene glycol norbornene is 2.0 wt%-5.0 wt%;
[0055] The hyaluronic acid norbornene solution and the four-arm polyethylene glycol norbornene solution were mixed evenly in a certain proportion, and the mixed solution and the primary epidermal stem cells were mixed evenly to obtain a cell-containing norbornene-modified compound mixed solution B; the number of cells was 1*10 5 Pieces / mL-1*10 6 Pieces / mL;
[0056] Step 3: Mix equal volumes of collagen tetrazine solution A in step 1 and norbornene-modified compound mixed solution B containing cells in step 2, transfer them into a cell culture device as needed, let them stand to form a hydrogel, add cell culture medium and culture them to obtain skin organoids.
[0057] In step 5.3 of the present invention, the hyaluronic acid norbornene solution, the four-arm polyethylene glycol norbornene solution and the 10 mM PBS solution in the step are uniformly mixed in a certain volume ratio to obtain hydrogels with different PEG contents;
[0058] The ratios thereof may be 1:0:0, 1:0.04:0.01, 1:0.09:0.02, 1:0.21:0.04, 1:0.36:0.07, 1:0.56:1.12, thereby obtaining a mixed solution B, in which the percentage of PEG-Nb to total Nb is 0%, 5%, 10%, 20%, 30% or 40%.
[0059] In the present invention, the extraction and culture method of primary epidermal stem cells is:
[0060] The human foreskin tissue was soaked in iodine for 5 minutes, disinfected with 75% alcohol for 1 minute, washed twice with PBS containing 10% double antibody, cut into 1cm x 1cm tissue blocks with ophthalmic scissors, digested with neutral protease at 37°C for 2 hours, separated the dermis and epidermis with ophthalmic scissors, added with 0.25% trypsin to the separated epidermal tissue and digested at 37°C for 15 minutes, filtered the digested tissue with 100μm and 40μm cell sieves to obtain a cell suspension, centrifuged at 1500rpm for 5 minutes to obtain a cell precipitate, and resuspended and cultured in a special culture medium for epidermal cells.
[0061] The present invention provides a skin organoid culture hydrogel and a preparation method thereof, which has the following beneficial effects :
[0062] (1) Compared with the commercial product Matrigel, the hydrogel of the present invention can culture organoids of larger size. In addition, the hydrogel of the present invention has clear composition, low immunogenicity, a wide range of adjustable mechanical properties, and can be used for in vivo transplantation.
[0063] (2) Compared with ionic crosslinking and photocrosslinking (GelMA, HAMA, etc.), the hydrogel of the present invention has better biocompatibility and the formed hydrogel network has fewer structural defects.
[0064] (3) The hydrogel of the present invention can adjust the molecular weight of hyaluronic acid and the type of collagen according to the needs of different cells in the skin composition, and incorporate four-arm polyethylene glycol according to the needs of structural and mechanical properties. BRIEF DESCRIPTION OF THE DRAWINGS
[0065] Figure 1 It is the UV-visible scanning image of 3Col and 3Col-Tz in Example 1;
[0066] Figure 2 is the NMR spectra of HA10 and HA10-Nb in Example 1;
[0067] Figure 3 is the NMR spectra of PEG-Nb and PEG-Nb in Example 1;
[0068] Figure 4 This is the mechanical properties diagram of 3ColHA10P0 hydrogel in Example 1;
[0069] Figure 5 This is an optical photograph of the 3ColHA10P0 hydrogel in Example 1;
[0070] Figure 6 is the self-healing ability of 3ColHA10P0 hydrogel in Example 1;
[0071] Figure 7 The self-healing ability of 3ColHA10P30 hydrogel in Example 1;
[0072] Figure 8 These are photos of the growth of skin organoids in 3ColHA10P0, 3ColHA10P5, 3ColHA10P10, 3ColHA10P20, and 3ColHA10P30 hydrogels in Example 1 on the first day;
[0073] Fig. 9 These are photos of the growth of skin organoids in 3ColHA10P0, 3ColHA10P5, 3ColHA10P10, 3ColHA10P20, and 3ColHA10P30 hydrogels in Example 1 on the third day;
[0074] Fig.10 These are photos of the growth of skin organoids in 3ColHA10P0, 3ColHA10P5, 3ColHA10P10, 3ColHA10P20, and 3ColHA10P30 hydrogels in Example 1 on the 5th day;
[0075] Fig.11It is a bar graph showing the change in size of skin organoids in 3ColHA10P0, 3ColHA10P5, 3ColHA10P10, 3ColHA10P20, and 3ColHA10P30 hydrogels over time in Example 1;
[0076] Fig.12 It is a bar graph showing the change in the number of skin organoids in 3ColHA10P0, 3ColHA10P5, 3ColHA10P10, 3ColHA10P20, and 3ColHA10P30 hydrogels over time in Example 1;
[0077] Fig.13 These are photos of the growth of skin organoids in commercial Matrigel on days 1, 3, and 5;
[0078] Fig.14 This is the NMR spectrum of the product HA40-Nb in Example 2;
[0079] Fig.15 This is the NMR spectrum of the product HA10-Nb in Example 3;
[0080] Fig.16 This is the NMR spectrum of the product HA40-Nb in Example 4. DETAILED DESCRIPTION
[0081] The present invention will be further described below in conjunction with specific embodiments and accompanying drawings:
[0082] Example 1
[0083] Preparation of hydrogels for skin organoid culture
[0084] Step 1: The preparation method of collagen tetrazine (3Col-Tz) is as follows:
[0085] Step 1.1: Under the condition of room temperature and stirring at 250 rpm, 100 mg of type III collagen was dissolved in 8 mL of PBS buffer solution with a pH of 9.0, and the solution was fully stirred to obtain a collagen solution (1.25 wt%), wherein the NH2 content in type III collagen was 1.82 mmol / g;
[0086] Step 1.2: Weigh 59.5 mg of methyl tetrazine active ester (Tz-NHS) and dissolve it in 2 mL of DMSO solution. After it is completely dissolved, add it dropwise to the collagen solution in step 1 so that the molar ratio of Tz-NHS to the amino group in collagen is NHS:NH2=1.0. React for 12 hours at room temperature and stirring at 250 rpm. Add 40 mL of pure water to terminate the reaction. Transfer the reaction solution to a dialysis bag with a molecular weight cutoff of 8-14 kDa and dialyze for 3 days. After freeze-drying for 48 hours, a pink sponge-like collagen tetrazine (3Col-Tz) is obtained, which is stored in a refrigerator at -20°C for later use.
[0087] Step 2: The preparation method of hyaluronic acid norbornene is as follows:
[0088] Step 2.1: Under room temperature and stirring conditions, 100 mg of sodium hyaluronate with a molecular weight of 10-15 kDa was dissolved in 10 mL of a 100 mM MES buffer solution with a pH of 6.5, and stirred overnight to completely dissolve the solution to obtain a sodium hyaluronate solution (1 wt%), wherein the COOH content of the sodium hyaluronate was 2.48 mmol / g;
[0089] Step 2.2: Weigh 142.7 mg, 1.24 mmol, of N-hydroxysuccinimide (NHS) and 237.7 mg, 1.24 mmol, of 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (EDC), add the sodium hyaluronate solution prepared in step 2.1 under stirring to make the molar ratio of NHS:EDC:COOH=5:5:1, stir and perform activation reaction for 0.5 hour to obtain an activated sodium hyaluronate solution;
[0090] Step 2.3: Measure 31.8 μL of 5-norbornene-2-methylamine (Nb-NH2) solution, and add the activated sodium hyaluronate solution in step 2.2 dropwise under stirring to make the molar ratio Nb-NH2:COOH = 1.0, stir the reaction for 16 hours, add 40 mL of pure water to terminate the reaction, transfer the reaction solution to a dialysis bag with a molecular weight cutoff of 8-14 kDa, dialyze for 4 days, and freeze-dry to obtain white spongy hyaluronic acid norbornene (HA-Nb), which is stored in a refrigerator at -20°C for later use.
[0091] Step 3: The preparation method of four-arm polyethylene glycol norbornene (PEG-Nb) is as follows:
[0092] Step 3.1: Under room temperature and stirring conditions, dissolve 100 mg of four-arm polyethylene glycol amino with a molecular weight of 10k in 9.8 mL of PBS buffer solution with a pH of 9.0, and stir for 10 minutes to completely dissolve it to obtain a four-arm polyethylene glycol amino solution;
[0093] Step 3.2: Weigh 11.2 mg of nadic anhydride (Nb-COOH) powder, add the four-arm polyethylene glycol amino solution prepared in step 3.1 under stirring to make the molar ratio Nb-COOH:NH2=1.0. During the dissolution of nadic anhydride, monitor the pH value of the reaction solution and adjust the pH of the solution to 9.0 with 10M NaOH solution. React for 16 hours at room temperature with stirring, add 40 mL of pure water to terminate the reaction, transfer the reaction solution to a dialysis bag with a molecular weight cutoff of 8-14 kDa, dialyze for 3 days, and lyophilize to obtain white sponge-like polyethylene glycol nadic anhydride (PEG-Nb), which is stored in a refrigerator at -20°C for later use.
[0094] Step 4: The preparation method of collagen tetrazine solution A is as follows;
[0095] 10 mg of collagen tetrazine in step 1 was weighed and dissolved in 0.41 mL of 10 mM PBS buffer solution, and sterilized to obtain a sterile collagen tetrazine solution A, wherein the final concentration of collagen tetrazine was 2.4 wt %.
[0096] Step 5: The preparation method of the norbornene modified compound mixed solution B is as follows;
[0097] Step 5.1: Weigh 15 mg of hyaluronic acid norbornene in step 2 and dissolve it in 0.50 mL of 10 mM PBS buffer solution, and treat it aseptically to obtain a sterile hyaluronic acid norbornene solution, wherein the final concentration of hyaluronic acid norbornene is 3.0 wt%.
[0098] Step 5.2: Weigh 10 mg of the four-arm polyethylene glycol norbornene in step 3 and dissolve it in 0.20 mL of 10 mM PBS buffer solution, and treat it aseptically to obtain a sterile four-arm polyethylene glycol norbornene solution, wherein the final concentration of the four-arm polyethylene glycol norbornene is 5.0 wt%.
[0099] Step 5.3: The hyaluronic acid norbornene solution in step 5.1, the four-arm polyethylene glycol norbornene solution in step 5.2 and 10 mM PBS solution are mixed uniformly in a certain volume ratio (1:0:0, 1:0.04:0.01, 1:0.09:0.02, 1:0.21:0.04, 1:0.36:0.07, 1:0.56:1.12) to obtain a mixed solution B, in which the percentage of PEG-Nb in the total Nb is 0%, 5%, 10%, 20%, 30% or 40%.
[0100] Step 6: The preparation method of skin organoid culture hydrogel is:
[0101] The collagen tetrazine solution A in step 4 and the norbornene-modified compound mixed solution B in step 5 were mixed evenly, transferred into the device, and allowed to stand for 0.5 hours to form a skin organoid culture hydrogel.
[0102] The method for applying hydrogel in skin organoid culture includes the following steps:
[0103] Step 1: Preparation of collagen tetrazine solution A containing cells;
[0104] Weigh 10 mg of collagen tetrazine in step 1 and dissolve it in 0.41 mL of 10 mM PBS buffer solution, and treat aseptically to obtain a sterile collagen tetrazine solution;
[0105] The collagen tetrazine solution and the primary epidermal stem cells were mixed evenly to obtain a collagen tetrazine solution A containing cells, wherein the final concentration of the collagen tetrazine was 2.4 wt % and the number of cells was 5*10 5 Pieces / mL.
[0106] Step 2: Preparation of norbornene-modified compound mixed solution B;
[0107] Weigh 15 mg of hyaluronic acid norbornene in step 2 and dissolve it in 0.50 mL of 10 mM PBS buffer solution, and treat aseptically to obtain a sterile hyaluronic acid norbornene solution, wherein the final concentration of hyaluronic acid norbornene is 3.0 wt %;
[0108] Weigh 10 mg of the four-arm polyethylene glycol norbornene in step 3 and dissolve it in 0.20 mL of 10 mM PBS buffer solution, and treat aseptically to obtain a sterile four-arm polyethylene glycol norbornene solution, wherein the final concentration of the four-arm polyethylene glycol norbornene is 5.0 wt %;
[0109] The above-mentioned hyaluronic acid norbornene solution, four-arm polyethylene glycol norbornene solution and 10mM PBS solution were mixed uniformly in a certain volume ratio (1:0:0, 1:0.04:0.01, 1:0.09:0.02, 1:0.21:0.04, 1:0.36:0.07, 1:0.56:1.12) to obtain a mixed solution B, in which the percentage of PEG-Nb in the total Nb was 0%, 5%, 10%, 20%, 30% or 40%.
[0110] Step 3: Evenly mix equal volumes of collagen tetrazine solution A containing cells and norbornene-modified compound mixed solution B, transfer them into a cell culture plate as needed, let them stand for 0.5 hours, add cell culture medium and culture them to obtain skin organoids.
[0111] About the product analysis in Example 1:
[0112] The hydrogels prepared in Example 1 were named 3ColHA10P0, 3ColHA10P5, 3ColHA10P10, 3ColHA10P20, 3ColHA10P30, and 3ColHA10P40.
[0113] Among them, 3Col represents the tetrazine-modified type III collagen 3Col-Tz;
[0114] HA10 represents HA10-Nb with a molecular weight of 10 - 15 kDa;
[0115] P0 - P40 represents that the percentage of PEG-Nb in the total Nb is 0%, 5%, 10%, 20%, 30%, or 40%.
[0116] Figure 1 is the UV-visible scanning diagram of 3Col and 3Col-Tz in Example 1. From this, the grafting rate of the product Col-Tz was calculated to be 25.6%.
[0117] Figure 2 is the NMR spectrum of HA10 and HA10-Nb in Example 1. From this, the grafting rate of the product HA-Nb was calculated to be 15.3%.
[0118] Figure 3 is the NMR spectrum of PEG-Nb and PEG-Nb in Example 1. From this, the grafting rate of the product PEG-Nb was calculated to be 68.2%.
[0119] Figure 4 is the mechanical property diagram of the 3ColHA10P0 hydrogel in Example 1, showing the changes of storage modulus (G’) and loss modulus (G”) with shear stress.
[0120] Figure 5 is the optical photograph of the 3ColHA10P0 hydrogel in Example 1. Figure 5 As can be seen, when 3Col and HA10 were just mixed evenly, they were still in a solution state. After standing for half an hour, they became a gel state.
[0121] Figure 6 is the self-healing ability of the 3ColHA10P0 hydrogel in Example 1. Figure 6 As can be seen, when the strain is 1%, G’ > G” and the hydrogel is in a gel state; when the strain is 1000%, G’ < G” and the hydrogel is in a solution state. When the strain returns to 1% again, it becomes a gel state again; indicating that the hydrogel has good self-healing ability and can be used for in vivo injection.
[0122] Figure 7 is the self-healing ability of the 3ColHA10P30 hydrogel in Example 1. Figure 7It can be seen that when the strain is 1%, the G’>G” hydrogel is in a gel state; when the strain is 1000%, the G’<G” hydrogel is in a solution state. When the strain returns to 1% again, it becomes gel-like again, indicating that the hydrogel has good self-healing ability and can be used for in vivo injection.
[0123] Figure 8 Growth photos of skin organoids on the first day in 3ColHA10P0, 3ColHA10P5, 3ColHA10P10, 3ColHA10P20, and 3ColHA10P30 hydrogels in Example 1; the scale bar in the figure is 100μm, by Figure 8 It can be seen from the figure that cell spheres are formed in 3ColHA10P20 on the first day of culture, indicating that the 3D culture of epidermal stem cells with this hydrogel can quickly promote the formation of cell spheres.
[0124] Fig. 9 Growth photos of skin organoids on the third day in 3ColHA10P0, 3ColHA10P5, 3ColHA10P10, 3ColHA10P20, and 3ColHA10P30 hydrogels in Example 1; the scale bar in the figure is 100μm, by Fig. 9 It can be seen that skin organoids are formed in 3ColHA10P0, 3ColHA10P5, 3ColHA10P10, 3ColHA10P20, and 3ColHA10P30 after 3 days of culture.
[0125] Fig.10 Growth photos of skin organoids on the fifth day in 3ColHA10P0, 3ColHA10P5, 3ColHA10P10, 3ColHA10P20, and 3ColHA10P30 hydrogels in Example 1; the scale bar in the figure is 100μm, by Fig.10 It can be seen that the volume of skin organoids further increases on the fifth day, indicating that this hydrogel helps to increase the volume of skin organoids.
[0126] Fig.11 Bar chart showing the change in the size of skin organoids over time in 3ColHA10P0, 3ColHA10P5, 3ColHA10P10, 3ColHA10P20, and 3ColHA10P30 hydrogels in Example 1. By Fig.11 It can be seen from the figure that as the culture time of skin organoids extends, their volume gradually increases.
[0127] Fig.12 Bar chart showing the change in the number of skin organoids over time in 3ColHA10P0, 3ColHA10P5, 3ColHA10P10, 3ColHA10P20, and 3ColHA10P30 hydrogels in Example 1. By Fig.12 It can be seen that the number of skin organoids increased in the first three days of culture in the hydrogel, and the number of skin organoids stopped increasing on the fifth day, indicating that the first three days in the skin organoid culture process are the critical period for the formation of skin organoids.
[0128] Fig.13 These are growth photos of skin organoids in commercially available Matrigel on days 1, 3, and 5, respectively; the scale in the figure is 100 μm. It can be seen from the figure that the size of the skin organoids in Matrigel is much smaller than that of the skin organoids in the patent of the present invention.
[0129] Example 2
[0130] Preparation of hydrogels for skin organoid culture
[0131] Step 1: The preparation method of collagen tetrazine (1Col-Tz) is as follows:
[0132] Step 1.1: Dissolve 100 mg of type I collagen in 8 mL of PBS buffer solution with a pH of 8.0 at room temperature and under stirring at 250 rpm, and stir thoroughly to dissolve to obtain a collagen solution (1.0 wt%);
[0133] Step 1.2: Weigh 178.5 mg of methyl tetrazine active ester (Tz-NHS) and dissolve it in 2 mL of DMSO solution. After it is completely dissolved, add it dropwise to the collagen solution in step 1.1 so that the molar ratio of Tz-NHS to the amino group in collagen is NHS:NH2=3.0. React for 24 hours at room temperature and stirring at 250 rpm. Add 40 mL of pure water to terminate the reaction. Transfer the reaction solution to a dialysis bag with a molecular weight cutoff of 8-14 kDa and dialyze for 3 days. After freeze-drying for 48 hours, a pink sponge-like collagen tetrazine (1Col-Tz) is obtained, which is stored in a refrigerator at -20°C for later use.
[0134] Step 2: The preparation method of hyaluronic acid norbornene is as follows:
[0135] Step 2.1: Under room temperature and stirring conditions, 100 mg of sodium hyaluronate with a molecular weight of 10-15 kDa was dissolved in 10 mL of a 100 mM MES buffer solution with a pH of 5.0, and stirred overnight to completely dissolve the solution to obtain a sodium hyaluronate solution, wherein the COOH content of the sodium hyaluronate was 2.48 mmol / g;
[0136] Step 2.2: Weigh 28.5 mg, 0.248 mmol of N-hydroxysuccinimide (NHS) and 47.5 mg, 0.248 mmol of 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (EDC), add the sodium hyaluronate solution prepared in step 2.1 under stirring to make the molar ratio of NHS:EDC:COOH=1:1:1, stir and perform activation reaction for 1.0 hour to obtain an activated sodium hyaluronate solution;
[0137] Step 2.3: Measure 63.6 μL of 5-norbornene-2-methylamine (Nb-NH2) solution, and add the activated sodium hyaluronate solution in step 2.2 dropwise under stirring to make the molar ratio of Nb-NH2:COOH=2, stir the reaction for 8 hours, add 40 mL of pure water to terminate the reaction, transfer the reaction solution to a dialysis bag with a molecular weight cutoff of 8-14 kDa, dialyze for 4 days, and freeze-dry to obtain white spongy hyaluronic acid norbornene (HA-Nb), which is stored in a refrigerator at -20°C for later use.
[0138] Step 3: The preparation method of four-arm polyethylene glycol norbornene (PEG-Nb) is as follows:
[0139] Step 3.1: Under room temperature and stirring conditions, dissolve 100 mg of four-arm polyethylene glycol amino with a molecular weight of 10k in 9.8 mL of PBS buffer solution with a pH of 8.0, and stir for 10 minutes to completely dissolve it to obtain a four-arm polyethylene glycol amino solution;
[0140] Step 3.2: Weigh 11.2 mg of nadic anhydride (Nb-COOH) powder, add the four-arm polyethylene glycol amino solution prepared in step 3.1 under stirring, so that the molar ratio Nb-COOH: NH2 = 0.5, monitor the pH value of the reaction solution during the dissolution of nadic anhydride and adjust the pH of the solution to 8.0 with 10M NaOH solution, react for 6 hours at room temperature under stirring, add 40 mL of pure water to terminate the reaction, transfer the reaction solution to a dialysis bag with a molecular weight cutoff of 8-14 kDa, dialyze for 3 days, and lyophilize to obtain white sponge-like polyethylene glycol nadic anhydride (PEG-Nb), which is stored in a refrigerator at -20°C for later use.
[0141] Step 4: The preparation method of collagen tetrazine solution A is as follows;
[0142] Weigh 10 mg of collagen tetrazine from step 1 and dissolve it in 0.41 mL of 10 mM PBS buffer solution, and treat aseptically to obtain a sterile collagen tetrazine solution. The final concentration of collagen tetrazine is 2.4 wt %.
[0143] Step 5: The preparation method of the norbornene modified compound mixed solution B is as follows;
[0144] Step 5.1: Weigh 15 mg of hyaluronic acid norbornene in step 2 and dissolve it in 0.50 mL of 10 mM PBS buffer solution, and treat it aseptically to obtain a sterile hyaluronic acid norbornene solution, wherein the final concentration of hyaluronic acid norbornene is 3.0 wt%.
[0145] Step 5.2: Weigh 10 mg of the four-arm polyethylene glycol norbornene in step 3 and dissolve it in 0.20 mL of 10 mM PBS buffer solution, and treat it aseptically to obtain a sterile four-arm polyethylene glycol norbornene solution, wherein the final concentration of the four-arm polyethylene glycol norbornene is 5.0 wt%.
[0146] Step 5.3: The hyaluronic acid norbornene solution, the four-arm polyethylene glycol norbornene solution and the 10 mM PBS solution were mixed uniformly at a volume ratio of 1:0.36:0.07 to obtain a mixed solution B, in which the percentage of PEG-Nb in the total Nb was 30%.
[0147] Step 6: The preparation method of skin organoid culture hydrogel is:
[0148] The collagen tetrazine solution A in step 4 and the norbornene-modified compound mixed solution B in step 5 were mixed evenly, transferred into the device, and allowed to stand for 0.5 hours to form a skin organoid culture hydrogel.
[0149] The method for applying hydrogel in skin organoid culture includes the following steps:
[0150] Step 1: Preparation of collagen tetrazine solution A containing cells;
[0151] Weigh 10 mg of collagen tetrazine in step 1 and dissolve it in 0.41 mL of 10 mM PBS buffer solution, and treat aseptically to obtain a sterile collagen tetrazine solution; mix the collagen tetrazine solution and the primary epidermal stem cells evenly to obtain a cell-containing collagen tetrazine solution A, wherein the final concentration of the collagen tetrazine is 2.4 wt % and the number of cells is 5*10 5 Pieces / mL.
[0152] Step 2: Preparation of norbornene-modified compound mixed solution B;
[0153] Weigh 15 mg of hyaluronic acid norbornene in step 2 and dissolve it in 0.50 mL of 10 mM PBS buffer solution, and treat aseptically to obtain a sterile hyaluronic acid norbornene solution, wherein the final concentration of hyaluronic acid norbornene is 3.0 wt %;
[0154] Weigh 10 mg of the four-arm polyethylene glycol norbornene in step 3 and dissolve it in 0.20 mL of 10 mM PBS buffer solution, and treat aseptically to obtain a sterile four-arm polyethylene glycol norbornene solution, wherein the final concentration of the four-arm polyethylene glycol norbornene is 5.0 wt %;
[0155] The hyaluronic acid norbornene solution, the four-arm polyethylene glycol norbornene solution and the 10 mM PBS solution were mixed uniformly at a volume ratio of 1:0.36:0.07 to obtain a mixed solution B, in which the percentage of PEG-Nb in the total Nb was 30%;
[0156] Step 3: Mix equal volumes of the cell-containing collagen tetrazine solution A in step 1 and the norbornene-modified compound mixed solution B in step 2, transfer them to a cell culture plate as needed, let them stand for 0.5 hours, add cell culture medium and culture them to obtain skin organoids.
[0157] About the product analysis in Example 2:
[0158] The hydrogel prepared in Example 2 is named 1ColHA40P30.
[0159] Among them, 1Col represents the tetrazine-modified type I collagen 1Col-Tz;
[0160] HA40 represents HA40-Nb with a molecular weight of 40.2 kDa;
[0161] P30 means that the percentage of PEG-Nb in the total Nb is 30%.
[0162] Fig.14 is the NMR spectrum of the product HA40-Nb in Example 2, Fig.14 The calculated grafting rate of HA40-Nb is 15.3%.
[0163] Example 3
[0164] Preparation of hydrogels for skin organoid culture
[0165] (1) The preparation method of collagen tetrazine (4Col-Tz) is as follows:
[0166] Step 1.1: Dissolve 200 mg of type IV collagen in 8 mL of PBS buffer solution with a pH of 10.0 at room temperature and under stirring at 250 rpm, and stir thoroughly to dissolve to obtain a collagen solution (2.5 wt %);
[0167] Step 1.2: Weigh 59.5 mg of methyl tetrazine active ester (Tz-NHS) and dissolve it in 2 mL of DMSO solution. After it is completely dissolved, add it dropwise to the collagen solution in step 1.1 so that the molar ratio of Tz-NHS to the amino group in collagen is NHS:NH2=0.5. React for 6 hours at room temperature and stirring at 250 rpm. Add 40 mL of pure water to terminate the reaction. Transfer the reaction solution to a dialysis bag with a molecular weight cutoff of 8-14 kDa and dialyze for 3 days. After freeze-drying for 48 hours, a pink sponge-like collagen tetrazine (4Col-Tz) is obtained, which is stored in a refrigerator at -20°C for later use.
[0168] (2) The preparation method of hyaluronic acid norbornene is as follows:
[0169] Step 2.1: Under room temperature and stirring conditions, 100 mg of sodium hyaluronate with a molecular weight of 10-15 kDa was dissolved in 10 mL of a 100 mM MES buffer solution with a pH of 6.0, and stirred overnight to completely dissolve the solution to obtain a sodium hyaluronate solution, wherein the COOH content of the sodium hyaluronate was 2.48 mmol / g;
[0170] Step 2.2: Weigh 285.4 mg, 2.48 mmol, of N-hydroxysuccinimide (NHS) and 475.4 mg, 2.48 mmol, of 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (EDC), add the sodium hyaluronate solution prepared in step 2.1 under stirring to make the molar ratio of NHS:EDC:COOH=10:10:1, stir and perform activation reaction for 2.0 hours to obtain an activated sodium hyaluronate solution;
[0171] Step 2.3: Measure 318 μL of 5-norbornene-2-methylamine (Nb-NH2) solution, and add the activated sodium hyaluronate solution in step 2.2 dropwise under stirring to make the molar ratio Nb-NH2:COOH = 10.0, stir the reaction for 48 hours, add 40 mL of pure water to terminate the reaction, transfer the reaction solution to a dialysis bag with a molecular weight cutoff of 8-14 kDa, dialyze for 4 days, and freeze-dry to obtain white spongy hyaluronic acid norbornene (HA100-Nb), which is stored in a refrigerator at -20°C for later use.
[0172] (3) The preparation method of four-arm polyethylene glycol norbornene (PEG-Nb) is as follows:
[0173] Step 3.1: Under room temperature and stirring conditions, dissolve 100 mg of four-arm polyethylene glycol amino with a molecular weight of 10 kDa in 9.8 mL of PBS buffer solution with a pH of 10.0, and stir for 10 minutes to completely dissolve it to obtain a four-arm polyethylene glycol amino solution;
[0174] Step 3.2: Weigh 11.2 mg of nadic anhydride (Nb-COOH) powder, add the four-arm polyethylene glycol amino solution prepared in step 3.1 under stirring to make the molar ratio Nb-COOH:NH2=2.0. During the dissolution of nadic anhydride, monitor the pH value of the reaction solution and adjust the pH of the solution to 10.0 with 10M NaOH solution. React for 48 hours at room temperature with stirring, add 40 mL of pure water to terminate the reaction, transfer the reaction solution to a dialysis bag with a molecular weight cutoff of 8-14 kDa, dialyze for 3 days, and lyophilize to obtain white sponge-like polyethylene glycol nadic anhydride (PEG-Nb), which is stored in a refrigerator at -20°C for later use.
[0175] Step 4: The preparation method of collagen tetrazine solution A is as follows;
[0176] Weigh 10 mg of collagen tetrazine in step 1 and dissolve it in 0.41 mL of 10 mM PBS buffer solution, and treat aseptically to obtain sterile collagen tetrazine solution A. The final concentration of collagen tetrazine is 2.4 wt%.
[0177] Step 5: The preparation method of the norbornene modified compound mixed solution B is as follows;
[0178] Step 5.1: Weigh 15 mg of hyaluronic acid norbornene in step 2 and dissolve it in 0.560 mL of 10 mM PBS buffer solution, and treat it aseptically to obtain a sterile hyaluronic acid norbornene solution, wherein the final concentration of hyaluronic acid norbornene is 2.0 wt%.
[0179] Step 5.2: Weigh 10 mg of the four-arm polyethylene glycol norbornene in step 3 and dissolve it in 0.560 mL of 10 mM PBS buffer solution, and treat it aseptically to obtain a sterile four-arm polyethylene glycol norbornene solution, wherein the final concentration of the four-arm polyethylene glycol norbornene is 2.0 wt%.
[0180] Step 5.3: The hyaluronic acid norbornene solution, the four-arm polyethylene glycol norbornene solution and the 10 mM PBS solution were mixed uniformly at a volume ratio of 1:0.36:0.07 to obtain a mixed solution B, in which the percentage of PEG-Nb in the total Nb was 30%.
[0181] Step 6: The preparation method of skin organoid culture hydrogel is:
[0182] The collagen tetrazine solution A in step 4 and the norbornene-modified compound mixed solution B in step 5 were mixed evenly, transferred into the device, and allowed to stand for 0.5 hours to form a skin organoid culture hydrogel.
[0183] The method for applying hydrogel in skin organoid culture includes the following steps:
[0184] Step 1: Preparation of collagen tetrazine solution A containing cells;
[0185] Weigh 10 mg of collagen tetrazine in step 1 and dissolve it in 0.41 mL of 10 mM PBS buffer solution, and treat aseptically to obtain a sterile collagen tetrazine solution; mix the collagen tetrazine solution and the primary epidermal stem cells evenly to obtain a cell-containing collagen tetrazine solution A, wherein the final concentration of the collagen tetrazine is 2.4 wt % and the number of cells is 5*10 5 Pieces / mL.
[0186] Step 2: Preparation of norbornene-modified compound mixed solution B;
[0187] 15 mg of hyaluronic acid norbornene in step 2 was weighed and dissolved in 0.560 mL of 10 mM PBS buffer solution, and aseptically treated to obtain a sterile hyaluronic acid norbornene solution, wherein the final concentration of hyaluronic acid norbornene was 2.0 wt %.
[0188] Weigh 10 mg of the four-arm polyethylene glycol norbornene in step 3 and dissolve it in 0.560 mL of 10 mM PBS buffer solution, and treat aseptically to obtain a sterile four-arm polyethylene glycol norbornene solution, wherein the final concentration of the four-arm polyethylene glycol norbornene is 2.0 wt %;
[0189] The hyaluronic acid norbornene solution, the four-arm polyethylene glycol norbornene solution and the 10 mM PBS solution were mixed uniformly at a volume ratio of 1:0.36:0.07 to obtain a mixed solution B, in which the percentage of PEG-Nb in the total Nb was 30%.
[0190] Step 3: Mix equal volumes of the cell-containing collagen tetrazine solution A in step 1 and the norbornene-modified compound mixed solution B in step 2, transfer them to a cell culture plate as needed, let them stand for 0.5 hours, add cell culture medium and culture them to obtain skin organoids.
[0191] About the product analysis in Example 3:
[0192] The hydrogel prepared in Example 3 is named 4ColHA100P30.
[0193] Among them, 4Col represents the tetrazine-modified type IV collagen 4Col-Tz;
[0194] HA100 represents HA100-Nb with a molecular weight of 100–150 kDa;
[0195] P30 means that the percentage of PEG-Nb in the total Nb is 30%.
[0196] Fig.15 is the NMR spectrum of the product HA10-Nb in Example 3, Fig.15 The calculated grafting rate of HA40-Nb is 51.3%.
[0197] Example 4
[0198] Preparation of hydrogels for skin organoid culture
[0199] Step 1: The preparation method of collagen tetrazine (17Col-Tz) is as follows:
[0200] Step 1.1: Dissolve 100 mg of type XVII collagen in 8 mL of PBS buffer solution with a pH of 9.0 at room temperature and under stirring at 250 rpm, and stir thoroughly to dissolve to obtain a collagen solution (1.25 wt %);
[0201] Step 1.2: Weigh 59.5 mg of methyl tetrazine active ester (Tz-NHS) and dissolve it in 2 mL of DMSO solution. After it is completely dissolved, add it dropwise to the collagen solution in step 1.1 so that the molar ratio of Tz-NHS to the amino group in collagen is NHS:NH2=1.0. React for 12 hours at room temperature and stirring at 250 rpm. Add 40 mL of pure water to terminate the reaction. Transfer the reaction solution to a dialysis bag with a molecular weight cutoff of 8-14 kDa and dialyze for 3 days. After freeze-drying for 48 hours, a pink sponge-like collagen tetrazine (17Col-Tz) is obtained, which is stored in a refrigerator at -20°C for later use.
[0202] Step 2: The preparation method of hyaluronic acid norbornene is as follows:
[0203] Step 2.1: Under room temperature and stirring conditions, 50 mg of sodium hyaluronate with a molecular weight of 10-15 kDa is dissolved in 10 mL of a 100 mM MES buffer solution with a pH of 6.0, and stirred overnight to completely dissolve the solution to obtain a sodium hyaluronate solution, wherein the COOH content of the sodium hyaluronate is 2.48 mmol / g;
[0204] Step 2.2: Weigh 285.4 mg, 2.48 mmol, of N-hydroxysuccinimide (NHS) and 475.4 mg, 2.48 mmol, of 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (EDC), add the sodium hyaluronate solution prepared in step 2.1 under stirring to make the molar ratio of NHS:EDC:COOH=10:10:1, stir and perform activation reaction for 2.0 hours to obtain an activated sodium hyaluronate solution;
[0205] Step 2.3: Measure 318 μL of 5-norbornene-2-methylamine (Nb-NH2) solution, and add the activated sodium hyaluronate solution in step 2.2 dropwise under stirring to make the molar ratio Nb-NH2:COOH = 10.0, stir the reaction for 48 hours, add 40 mL of pure water to terminate the reaction, transfer the reaction solution to a dialysis bag with a molecular weight cutoff of 8-14 kDa, dialyze for 4 days, and freeze-dry to obtain white spongy hyaluronic acid norbornene (HA100-Nb), which is stored in a refrigerator at -20°C for later use.
[0206] Step 3: The preparation method of four-arm polyethylene glycol norbornene (PEG-Nb) is as follows:
[0207] The preparation method is the same as in Example 1.
[0208] Step 4: The preparation method of collagen tetrazine solution A is as follows;
[0209] 10 mg of collagen tetrazine in step 1 was weighed and dissolved in 0.704 mL of 10 mM PBS buffer solution, and sterilized to obtain a sterile collagen tetrazine solution A. The final concentration of the collagen tetrazine was 1.42 wt%.
[0210] Step 5: The preparation method of the norbornene modified compound mixed solution B is as follows;
[0211] Step 5.1: Weigh 11.2 mg of hyaluronic acid norbornene in step 2 and dissolve it in 0.560 mL of 10 mM PBS buffer solution, and treat it aseptically to obtain a sterile hyaluronic acid norbornene solution, wherein the final concentration of hyaluronic acid norbornene is 2.0 wt%.
[0212] Step 5.2: Weigh 11.2 mg of the four-arm polyethylene glycol norbornene in step 3 and dissolve it in 0.560 mL of 10 mM PBS buffer solution, and treat it aseptically to obtain a sterile four-arm polyethylene glycol norbornene solution, wherein the final concentration of the four-arm polyethylene glycol norbornene is 2.0 wt%.
[0213] Step 5.3: The hyaluronic acid norbornene solution, the four-arm polyethylene glycol norbornene solution and the 10 mM PBS solution were mixed uniformly at a volume ratio of 1:0.36:0.07 to obtain a mixed solution B, in which the percentage of PEG-Nb in the total Nb was 30%.
[0214] Step 6: The preparation method of skin organoid culture hydrogel is:
[0215] The collagen tetrazine solution A in step 4 and the norbornene-modified compound mixed solution B in step 5 were mixed evenly, transferred into the device, and allowed to stand for 0.5 hours to form a skin organoid culture hydrogel.
[0216] The method for applying hydrogel in skin organoid culture includes the following steps:
[0217] Step 1: Preparation of collagen tetrazine solution A;
[0218] 10 mg of collagen tetrazine in step 1 was weighed and dissolved in 0.704 mL of 10 mM PBS buffer solution, and sterilized to obtain a sterile collagen tetrazine solution A. The final concentration of the collagen tetrazine was 1.42 wt%.
[0219] Step 2: Preparation of a mixed solution B of norbornene-modified compounds containing cells;
[0220] 11.2 mg of hyaluronic acid norbornene in step 2 was weighed and dissolved in 0.560 mL of 10 mM PBS buffer solution, and aseptically treated to obtain a sterile hyaluronic acid norbornene solution, wherein the final concentration of hyaluronic acid norbornene was 2.0 wt %.
[0221] Weigh 11.2 mg of the four-arm polyethylene glycol norbornene in step 3 and dissolve it in 0.560 mL of a 10 mM PBS buffer solution, and treat aseptically to obtain a sterile four-arm polyethylene glycol norbornene solution, wherein the final concentration of the four-arm polyethylene glycol norbornene is 2.0 wt %;
[0222] The hyaluronic acid norbornene solution, the four-arm polyethylene glycol norbornene solution and the 10 mM PBS solution were mixed uniformly at a volume ratio of 1:0.36:0.07 to obtain a mixed solution B, in which the percentage of PEG-Nb in the total Nb was 30%.
[0223] The mixed solution B and the original epidermal stem cells were mixed evenly to obtain the cell-containing norbornene-modified compound mixed solution B, the number of cells was 1*10 6 Pieces / mL.
[0224] Step 3: Mix the collagen tetrazine solution A in step 1 and the cell-containing norbornene-modified compound mixed solution B in step 2 in equal volumes, transfer them into the cell culture plate as needed, let them stand for 2 hours, add cell culture medium and culture them to obtain skin organoids.
[0225] About the product analysis in Example 4:
[0226] The hydrogel prepared in Example 4 was named 17ColHA40P30.
[0227] Among them, 17Col represents the tetrazine-modified type XVII collagen 17Col-Tz;
[0228] HA40 represents HA40-Nb with a molecular weight of 40.2 kDa;
[0229] P30 means that the percentage of PEG-Nb in the total Nb is 30%.
[0230] Fig.16 is the NMR spectrum of the product HA40-Nb in Example 4, Fig.16 The calculated grafting rate of HA40-Nb is 35.4%.
[0231] Compared with the existing commercial Matrigel, the hydrogel of the present invention has clear components, no animal-derived components, low immunogenicity, meets implantation requirements, has good biocompatibility, and has adjustable mechanical properties.
[0232] The present invention is described exemplarily above in conjunction with the embodiments and drawings. It is obvious that the implementation of the present invention is not limited to the above-mentioned methods. As long as various improvements are made using the method concept and technical solution of the present invention, or the concept and technical solution of the present invention are directly applied to other occasions without improvement, they are all within the protection scope of the present invention.
Claims
1. A method for preparing a hydrogel for culturing skin organoids, characterized in that The steps include: Step 1: Synthesis of collagen tetrazine; Step 2: Synthesis of hyaluronic acid norbornene; Step 3: Synthesis of four-arm polyethylene glycol norbornene; Step 4: Preparation of collagen tetrazine solution A; Step 5: Preparation of norbornene-modified compound mixed solution B; Step 6: Preparation of hydrogel for skin organoid culture.
2. The method for preparing the skin organoid culture hydrogel according to claim 1, characterized in that: The synthesis of collagen tetrazine described in step 1 specifically comprises the following steps: Step 1.1: Under normal temperature and stirring conditions, dissolve collagen in a weak alkaline buffer solution, and fully stir and dissolve to obtain a collagen solution with a concentration of 1.25wt%-2.5wt%; Step 1.2: Weigh methyl tetrazine active ester (Tz-NHS) and dissolve it in DMSO solution. After it is completely dissolved, add it dropwise to the collagen solution of step 1.1, so that the molar ratio of Tz-NHS to the amino group in collagen is NHS:NH2=0.5-3.
0. React for 6-24 hours at room temperature with stirring, add pure water to terminate the reaction, dialyze, and freeze-dry to obtain pink sponge-like collagen tetrazine, which is stored in a refrigerator for later use; Wherein, the collagen described in step 1 includes type I collagen, type III collagen, type IV collagen, and type XVII collagen.
3. The method for preparing the skin organoid culture hydrogel according to claim 1, characterized in that: The method for synthesizing hyaluronic acid norbornene described in step 2 specifically comprises the following steps: Step 2.1: Dissolve sodium hyaluronate in a weakly acidic buffer solution at room temperature with stirring to completely dissolve the sodium hyaluronate solution; Step 2.2: Weigh N-hydroxysuccinimide (NHS) and 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (EDC) respectively, add the sodium hyaluronate solution prepared in step 2.1 under stirring to make the molar ratio of NHS:EDC:COOH=1:1:1-10:10:1, stir and perform activation reaction for 0.5-2 hours to obtain an activated sodium hyaluronate solution; Step 2.3: Measure 5-norbornene-2-methylamine (Nb-NH2) solution, and add the solution of step 2.2 dropwise under stirring to make the molar ratio of Nb-NH2:COOH=1.0-10.0, stir and react for 8-48 hours, add pure water to terminate the reaction, dialyze and freeze-dry to obtain white spongy hyaluronic acid norbornene, which is stored in a refrigerator for later use; Wherein, the molecular weight of the hyaluronic acid described in step 2 includes 10-15kDa, 40.2kDa, and 150-300kDa.
4. The method for preparing the hydrogel for skin organoid culture according to claim 1, characterized in that: The synthesis method of the four-arm polyethylene glycol norbornene described in step 3 specifically comprises the following steps: Step 3.1: Dissolve the four-arm polyethylene glycol amino in a buffer solution under stirring at room temperature, and stir to completely dissolve the four-arm polyethylene glycol amino solution; Step 3.2: Weigh the powder of nadic anhydride (Nb-COOH), add the four-arm polyethylene glycol amino solution prepared in step 3.1 under stirring, so that the molar ratio Nb-COOH:NH2=0.5-2.
0. During the dissolution of nadic anhydride, monitor the pH value of the reaction solution and adjust it. React at room temperature with stirring, add pure water to terminate the reaction, dialyze and freeze-dry to obtain white sponge-like polyethylene glycol nadic anhydride, which is stored in a refrigerator for later use.
5. The method for preparing the hydrogel for skin organoid culture according to claim 1, characterized in that: The preparation of the collagen tetrazine solution A described in step 4 is specifically as follows: weigh the collagen tetrazine prepared in step 1 and dissolve it in a buffer solution, and perform aseptic treatment to obtain a collagen tetrazine solution; The preparation of the norbornene modified compound mixed solution B described in step 5 is specifically as follows: Step 5.1: Weigh the hyaluronic acid norbornene prepared in step 2 and dissolve it in a buffer solution, and perform aseptic treatment to obtain a hyaluronic acid norbornene solution; Step 5.2: dissolving the four-arm polyethylene glycol norbornene in step 3 in a buffer solution, and aseptically treating the solution to obtain a four-arm polyethylene glycol norbornene solution; Step 5.3: The hyaluronic acid norbornene solution, four-arm polyethylene glycol norbornene solution and buffer solution in the above step are uniformly mixed at a certain volume ratio to obtain a norbornene-modified compound mixed solution B.
6. The method for preparing the hydrogel for culturing skin organoids according to claim 1, characterized in that: The specific operation for preparing the skin organoid culture hydrogel described in step 6 is: the collagen tetrazine solution A in step 4 and the norbornene modified compound mixed solution B in step 5 are mixed evenly, transferred into the device, and allowed to stand for 0.5-2 hours to form the skin organoid culture hydrogel.
7. A hydrogel prepared according to the method for preparing hydrogel for skin organoid culture according to any one of claims 1 to 6.
8. Use of the hydrogel according to any one of claims 1 to 6 in skin organoid culture, characterized in that The steps include: Wherein, the application method 1 comprises the following steps: Step 1: Preparation of collagen tetrazine solution A containing cells; Step 2: Preparation of norbornene-modified compound mixed solution B; Step 3: Evenly mix the cell-containing collagen tetrazine solution A in step 1 and the norbornene-modified compound mixed solution B in step 2 in equal volumes, transfer them into a cell culture device as required, allow them to stand for a while to form a hydrogel, then add cell culture medium for culture, and thus obtain skin organoids; Alternatively, the second application method includes the following steps: Step 1: Preparation of collagen tetrazine solution A; Step 2: Preparation of a mixed solution B of norbornene-modified compounds containing cells; Step 3: Mix equal volumes of collagen tetrazine solution A in step 1 and norbornene-modified compound mixed solution B containing cells in step 2, transfer them into a cell culture device as needed, let them stand to form a hydrogel, add cell culture medium and culture them to obtain skin organoids.
9. Use of the skin organoid culture hydrogel according to claim 8 in skin organoid culture, characterized in that: The application method 1 specifically comprises the following steps: Step 1: weigh the collagen tetrazine in step 1 and dissolve it in a buffer solution, and aseptically treat it to obtain a collagen tetrazine solution; mix the collagen tetrazine solution and the primary epidermal stem cells evenly to obtain a collagen tetrazine solution A containing cells, wherein the final concentration of the collagen tetrazine is 1.42wt%-2.4wt%, and the number of cells is 1*10 5 Pieces / mL-1*10 6 Pieces / mL; Step 2, weighing the hyaluronic acid norbornene in step 2 and dissolving it in a buffer solution, and aseptically treating it to obtain a hyaluronic acid norbornene solution, wherein the final concentration of the hyaluronic acid norbornene is 2.0wt%-3.0wt%; Weigh the four-arm polyethylene glycol norbornene in step 3 and dissolve it in a buffer solution, and aseptically treat it to obtain a four-arm polyethylene glycol norbornene solution, wherein the final concentration of the four-arm polyethylene glycol norbornene is 2.0 wt%-5.0 wt%; The hyaluronic acid norbornene solution and the four-arm polyethylene glycol norbornene solution are mixed uniformly in a certain ratio to obtain a norbornene modified compound mixed solution B; Step three, mix equal volumes of the cell-containing collagen tetrazine solution A in step one and the norbornene-modified compound mixed solution B in step two, transfer them into a cell culture device as needed, let them stand to form a hydrogel, add cell culture medium and culture them to obtain skin organoids.
10. Use of the skin organoid culture hydrogel according to claim 8 in skin organoid culture, characterized in that: The second application method comprises the following steps: Step 1, weighing the collagen tetrazine prepared in step 1 and dissolving it in a buffer solution, and aseptically treating the solution to obtain a collagen tetrazine solution A; wherein the final concentration of the collagen tetrazine is 1.42wt%-2.4wt%; Step 2, weighing the hyaluronic acid norbornene in step 2 and dissolving it in a buffer solution, and aseptically treating it to obtain a hyaluronic acid norbornene solution, wherein the final concentration of the hyaluronic acid norbornene is 2.0wt%-3.0wt%; Weigh the four-arm polyethylene glycol norbornene in step 3 and dissolve it in a buffer solution, and aseptically treat it to obtain a four-arm polyethylene glycol norbornene solution, wherein the final concentration of the four-arm polyethylene glycol norbornene is 2.0 wt%-5.0 wt%; The hyaluronic acid norbornene solution and the four-arm polyethylene glycol norbornene solution were mixed evenly in a certain proportion, and the mixed solution and the primary epidermal stem cells were mixed evenly to obtain a cell-containing norbornene-modified compound mixed solution B; the number of cells was 1*10 5 Pieces / mL-1*10 6 Pieces / mL; Step 3: Mix equal volumes of collagen tetrazine solution A in step 1 and norbornene-modified compound mixed solution B containing cells in step 2, transfer them into a cell culture device as needed, let them stand to form a hydrogel, add cell culture medium and culture them to obtain skin organoids.
